Marco Quarta

Marco Quarta

Company: Rubedo Life Sciences

Job title: Co-Founder & Chief Executive Officer

Seminars:

A Novel First-in-Class Senolytic Therapy for Treating Various Chronic Inflammatory Skin Conditions 4:30 pm

Chronic skin conditions like atopic dermatitis, psoriasis, and rosacea share an inflammatory environment that hinders healing Senescent cells contribute to this inflammation, driving immune responses that worsen disease progression and tissue degeneration, especially with aging Rubedo's Alembic platform identifies different types of senescent cells in diseased tissues. Using this platform, Rubedo develops selective senolytic drugs…Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.